1823 related articles for article (PubMed ID: 17110877)
1. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
2. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
[TBL] [Abstract][Full Text] [Related]
3. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
[TBL] [Abstract][Full Text] [Related]
4. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
5. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
6. Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit.
Morales IJ; Peters SG; Afessa B
Crit Care Med; 2003 Mar; 31(3):858-63. PubMed ID: 12626997
[TBL] [Abstract][Full Text] [Related]
7. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
[TBL] [Abstract][Full Text] [Related]
8. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
[TBL] [Abstract][Full Text] [Related]
9. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?
Shorr AF; Micek ST; Jackson WL; Kollef MH
Crit Care Med; 2007 May; 35(5):1257-62. PubMed ID: 17414080
[TBL] [Abstract][Full Text] [Related]
10. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic outcomes of the electronic intensive care unit: results from two community hospitals.
Morrison JL; Cai Q; Davis N; Yan Y; Berbaum ML; Ries M; Solomon G
Crit Care Med; 2010 Jan; 38(1):2-8. PubMed ID: 19730249
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
13. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission.
Ho PL;
Crit Care Med; 2003 Apr; 31(4):1175-82. PubMed ID: 12682490
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic burden of antimicrobial resistance.
Maragakis LL; Perencevich EN; Cosgrove SE
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
[TBL] [Abstract][Full Text] [Related]
15. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic use and cost indicators at a rural hospital: a pilot project.
Mylotte JM; Weislo P
Am J Infect Control; 2000 Dec; 28(6):415-20. PubMed ID: 11114611
[TBL] [Abstract][Full Text] [Related]
17. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.
Moran JL; Bristow P; Solomon PJ; George C; Hart GK;
Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383
[TBL] [Abstract][Full Text] [Related]
18. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999-2000.
Kozlow JH; Berenholtz SM; Garrett E; Dorman T; Pronovost PJ
Crit Care Med; 2003 Jul; 31(7):1930-7. PubMed ID: 12847385
[TBL] [Abstract][Full Text] [Related]
20. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
